ProPhase Labs Inc (PRPH)
5.25
+0.09
(+1.74%)
USD |
NASDAQ |
May 02, 12:06
ProPhase Labs Market Cap: 94.74M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 93.11M |
| April 30, 2024 | 83.19M |
| April 29, 2024 | 83.19M |
| April 26, 2024 | 84.99M |
| April 25, 2024 | 89.32M |
| April 24, 2024 | 91.31M |
| April 23, 2024 | 93.11M |
| April 22, 2024 | 88.42M |
| April 19, 2024 | 94.92M |
| April 18, 2024 | 98.17M |
| April 17, 2024 | 113.14M |
| April 16, 2024 | 132.63M |
| April 15, 2024 | 111.07M |
| April 12, 2024 | 117.65M |
| April 11, 2024 | 115.49M |
| April 10, 2024 | 110.62M |
| April 09, 2024 | 110.08M |
| April 08, 2024 | 119.10M |
| April 05, 2024 | 122.71M |
| April 04, 2024 | 118.74M |
| April 03, 2024 | 119.46M |
| April 02, 2024 | 124.33M |
| April 01, 2024 | 123.61M |
| March 28, 2024 | 116.75M |
| March 27, 2024 | 112.96M |
| Date | Value |
|---|---|
| March 26, 2024 | 113.50M |
| March 25, 2024 | 111.88M |
| March 22, 2024 | 105.38M |
| March 21, 2024 | 101.41M |
| March 20, 2024 | 99.79M |
| March 19, 2024 | 94.38M |
| March 18, 2024 | 92.75M |
| March 15, 2024 | 90.95M |
| March 14, 2024 | 87.70M |
| March 13, 2024 | 91.13M |
| March 12, 2024 | 86.62M |
| March 11, 2024 | 88.60M |
| March 08, 2024 | 85.71M |
| March 07, 2024 | 85.17M |
| March 06, 2024 | 82.83M |
| March 05, 2024 | 85.17M |
| March 04, 2024 | 83.19M |
| March 01, 2024 | 82.29M |
| February 29, 2024 | 80.66M |
| February 28, 2024 | 85.53M |
| February 27, 2024 | 90.77M |
| February 26, 2024 | 91.67M |
| February 23, 2024 | 89.50M |
| February 22, 2024 | 89.50M |
| February 21, 2024 | 89.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
13.91M
Minimum
Jun 26 2020
231.13M
Maximum
Jul 11 2022
91.36M
Average
91.02M
Median
Market Cap Benchmarks
| Fonar Corp | 104.00M |
| XWELL Inc | 7.405M |
| Applied DNA Sciences Inc | 3.495M |
| Veracyte Inc | 1.510B |
| OncoCyte Corp | 33.48M |
Market Cap Related Metrics
| PS Ratio | 2.074 |
| Price to Book Value | 1.918 |
| Price | 5.25 |
| Earnings Yield | -18.67% |